Clinical Trials
6 trialsNCT04967079 2024-04-23
Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC Patients
Shanghai Chest Hospital
Phase 1 Completed
NCT03743129 2023-06-12
ALTER-L029
Peking University Cancer Hospital & Institute
Phase 2 Completed
NCT04507906 2022-06-28
Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC
Shanghai Chest Hospital
Phase 1/2 Completed
NCT03736837 2021-03-15
ALTER-L004
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Completed
NCT02388919 2017-09-18
ALTER0303
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2/3 Completed
NCT01924195 2015-10-28
Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302）
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2 Completed